Loading company…
Won a federal SBIR/STTR research award from HHS and other federal agencies.
WAYPATH PHARMA LLC has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $225,000 in 2022. These are non-dilutive federal research grants, not equity financing. The company is based in METAIRIE, Louisiana.
No investors recorded yet for WAYPATH PHARMA LLC.
Add an investorWAYPATH PHARMA LLC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for WAYPATH PHARMA LLC.
Add diversity data